Most Recent Articles by Corinna Panlilio Sison, MD
Beta-blocker use was associated with less joint pain and lower use of opioids in patients with symptomatic, large joint radiographic OA.
In this meta-analysis, the researchers found that all TNF-α inhibitors were more effective at treating AS than placebo in direct comparisons, but no differences in efficacy or safety were found between individual TNF-α inhibitors in indirect comparisons.
Selective inhibition of JAK1 and JAK2 with baricitinib resulted in clinical improvements in RA symptoms and inhibited joint structural disease progression in patients with active RA who have failed csDMARDs.
The European League Against Rheumatism has released updated management guidelines to address cardiovascular disease risk assessment in patients with rheumatoid arthritis and other inflammatory arthritides.
More Articles by Corinna Panlilio Sison, MD
Rheumatology Advisor Articles
- FDA Clears Radiofrequency Treatment for Osteoarthritis Knee Pain
- Osteoporosis Treatment Receives Updated Guidelines From ACP
- Six Institutional Areas Tied to Physician Burnout
- Assessing the Diagnostic Accuracy of MRI in Early Rheumatoid Arthritis
- Superior Reduction in Osteoarthritis Knee Pain From Novel Hyaluronan Injection
- Knee Osteoarthritis: Intra-Articular Triamcinolone vs Saline Injection
- Knee Pain Relief From Fiber, Chondroitin in Osteoarthritis
- Bone Mineral Density Changes Related to Adrenal Incidentalomas in Menopause
- Patients Satisfied With Telemedicine Primary Care Visits
- HIV-Induced Osteoporosis Detected Via Bone Ultrasonography